Re:Pharmacokinetics: Drug Development's Broken Stair
by atombender on Sunday October 01, 2023 @10:39AM
(#37726342)
Don't know about 10x, but having the MTHFR mutation genotype 667TT reduces folate activation [1] by 70-80%, which is a problem with drugs that require folate supplementation, like methotrexate.
[1] https://www.snpedia.com/index.php/Rs1801133